7:01 AM ET
8-K
Investor Presentation
Harvard Bioscience Investor Presentation
Harvard Bioscience filed its updated corporate slide presentation for November 2026 to provide the investment community with updates and summaries of its business operations. The presentation includes forward-looking information regarding expected financial performance, including adjusted EBITDA margins and the introduction of new products aimed at accelerating drug development.